RSRanin Soliman

Ranin Soliman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ranin Soliman has a total of 91 co-authors. Here are the top co-authors by number of shared publications:

  • Carl Heneghan

    Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX1 2JD Oxford, UK

    9 shared publications
  • Manal Zamzam

    Paediatric Oncology Department, Children's Cancer Hospital Egypt - 57357, Egypt

    9 shared publications
  • Wael Eweida

    Chief Operating Office, Children's Cancer Hospital 57357 Egypt (CCHE), Cairo 4260102, Egypt

    9 shared publications
  • Alaa Elhaddad

    Paediatric Oncology Department, National Cancer Institute, Cairo University, Cairo 11796, Egypt

    8 shared publications
  • Jason Oke

    Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, OX1 2JD Oxford, UK

    8 shared publications
  • Sherif Abouelnaga

    Chief Executive Office, Children's Cancer Hospital 57357 Egypt (CCHE), Cairo 4260102, Egypt

    6 shared publications

Latest Publications

  • Open Access

    Effectiveness of Telehealth Care Interventions for Women’s Mental Health During and After the COVID-19 Pandemic: Systematic Review and Meta-Analysis

    by Serena Kao, Athina Marina Metaxa, Ranin Soliman, Ioannis Mitrogiannis, Francesco Rubino, Anastasija Arechvo, Valeria Mondelli

    Background: The COVID-19 pandemic has increased telemental health interventions. However, evidence of effectiveness in improving women’s mental health outcomes, acceptability, and user satisfaction remains fragmented. Objective: This study examined the effectiveness of telehealth interventions in alleviating depression, anxiety, and stress in women during and after the pandemic and descriptively summarized the acceptability of and satisfaction with these interventions. Methods: This systematic review and meta-analysis compared telemental health interventions with control conditions (waitlists or standard care) for women experiencing anxiety, depression, or stress. Databases (PubMed/MEDLINE, Embase, Web of Science, PsycINFO, and Cochrane Central Register of Controlled Trials) were searched through March 19, 2026. Eligible studies evaluated interventions in women aged 18 to 64 years (≥80% female participants and female-specific outcomes) and included randomized controlled trials (RCTs), nonrandomized trials, and observational studies with ≥5 participants using outcome measures. Random-effects meta-analyses were conducted for depression, anxiety, and stress using RCT data. Risk of bias was assessed using Cochrane tools and certainty of evidence using Grading of Recommendations, Assessment, Development and Evaluation. Results: Fifty-seven studies (N=13,457) from 24 countries, reported the effectiveness, acceptability, and satisfaction with telehealth interventions. Meta-analysis of 23 studies (n=3269) demonstrated significant benefits of telehealth interventions for depression, anxiety, and stress. Depression showed the greatest improvements, with a moderate reduction in symptoms (Hedges g =−0.56, 95% CI −0.86 to −0.26; P <.001), followed by anxiety (small to moderate reduction; Hedges g =−0.45, 95% CI −0.62 to −0.28; P <.001). Stress showed a smaller effect (Hedges g =−0.25, 95% CI −0.47 to −0.04; P =.02), indicating modest benefits. Heterogeneity was high, with 95% prediction intervals of −1.97 to 0.84, −1.11 to 0.21, and −0.98 to 0.40 for depression, anxiety, and stress, respectively. Subgroup analyses favored telehealth over waitlist and standard care for depression (waitlist: Hedges g =−0.60, 95% CI −0.86 to −0.33; standard care: Hedges g =−0.57, 95% CI −1.11 to −0.02; both P <.001) and anxiety (waitlist: Hedges g =−0.47, 95% CI −0.68 to −0.25; standard care: Hedges g =−0.52, 95% CI −0.80 to −0.25; both P <.001). Insufficient studies were available to evaluate stress in subgroup analyses. Treatment effects remained significant in female-only and predominantly female samples. Evidence certainty was downgraded due to heterogeneity, risk of bias, and methodological limitations. Conclusions: This is the first systematic review and meta-analysis focused on telemental health interventions for women. Telehealth was associated with moderate, small to moderate, and modest reductions in depression, anxiety, and stress, respectively, with benefits across female-only and predominantly female samples. Moderate to high heterogeneity in average effects (CIs), wide distributions of effects across settings (prediction intervals), and risk of bias resulted in moderate certainty of evidence. Overall, telehealth is a scalable approach for improving access to mental health care for women, although high-quality research is needed to strengthen the evidence base.

  • Open Access

    An overview of childhood cancer care and outcomes in Egypt: a narrative review

    by Ranin Soliman, Nancy Bolous, Carl Heneghan, Jason Oke, Anne-Marie Boylan, Wael Eweida, Sherif Abouelnaga, Alaa Elhaddad

    An overview of childhood cancer care and outcomes in Egypt: a narrative review Ranin Soliman1,2,3†, Nancy Bolous4†, Carl Heneghan5, Jason Oke5, Anne-Marie


  • Open Access

    Barriers and Facilitators to Implementing Cost-Effective Evidence-Based Childhood Cancer Treatment in a Resource-Limited Setting in Egypt: A Qualitative Interview Study

    by Ranin Soliman, Carl Heneghan, Anne-Marie Boylan, Jason Oke, Wael Eweida, Alaa Elhaddad

    PURPOSE: Childhood cancer treatment is complex, resource-intensive, and expensive, and resource-limited settings would benefit from providing cost-effective treatment approaches on the basis of evidence. Effective implementation of cost-effective evidence-based treatment requires knowledge about factors influencing its use. In this study, we determined the clinicians' perceptions of the barriers and facilitators to implementing cost-effective evidence-based treatment for children with cancer in a resource-limited pediatric oncology setting in Egypt. METHODS: We conducted a qualitative study on the basis of semistructured interviews with senior clinicians who make high-level decisions on treatment protocols and tailored decisions for the atypically complicated group of patients. Purposive sampling was used to recruit the participants. Thematic analysis was conducted semantically to develop themes of barriers and facilitators. RESULTS: Fourteen participants agreed to participate in the study: nine pediatric oncologists; three surgeons; and two radiation oncologists. We identified four main themes of barriers and facilitators: awareness and orientation; knowledge, skills, and attitudes; system, resources, and context; and clinical practice. The main barriers included absence of easily available costs/cost-effectiveness data, limited resources and inability to pay for expensive novel (cost-effective) drugs, and gap between evidence and practice. The main facilitators included adopting standard treatment protocols on the basis of clinical effectiveness, leadership support, availability of patients' clinical and cost data from local context, and existing knowledge and skills in clinical research and health economic evaluation. The interview participants also provided suggestions to promote the implementation of cost-effective evidence-based treatment in priority areas. CONCLUSION: Our study findings provide an understanding of the barriers and facilitators affecting the implementation of cost-effective evidence-based treatment for childhood cancers in Egypt. We provide practical recommendations to address the implementation gaps with implications on practice, policy, and research.


  • Open Access

    A context‐specific conceptual framework of evidence synthesis to improve childhood cancer health outcomes and resource use in Egypt: Using real‐world data and addressing the implementation gaps

    by Ranin Soliman

    Introduction: Given the large numbers of children with cancer in Egypt, the limited resources, and inferior survival outcomes, there is a need to better target resources to improve outcomes efficiently based on evidence. Nevertheless, there is a gap in knowledge about childhood cancer health outcomes and resource use in Egypt. This commentary presents a “context‐specific” conceptual framework of evidence synthesis to improve childhood cancer health outcomes and resource use in a resource‐limited setting in Egypt, using real‐world data and addressing the implementation gaps.Methods: Real‐world data is defined as data relating to health status and/or the delivery of health services routinely collected from various sources outside the contexts of randomized controlled trials that can be used to conduct prospective/retrospective observational research studies.Results: To better address this context‐specific clinical problem, the conceptual framework of evidence synthesis proposes to generate three types of evidence using hybrid research methods; (1) Real‐world evidence (obtained from observational studies based on routinely collected data from local context); (2) systematic evidence from the literature (systematic review); and (3) qualitative evidence based on experts' opinions in the local setting (interview study). Generating evidence from the three pillars altogether makes for a stronger approach to better research and tackle the local problem in this specific resource‐limited context, and address the implementation gaps.Conclusions: This framework serves as a methodological roadmap to generate relevant evidence in similar resource‐limited contexts in low‐ and middle‐income countries, where there is a paucity of published studies in the literature about childhood cancer survival outcomes and resource use.

  • Open Access

    Cost-effectiveness of childhood cancer treatment in Egypt: lessons to promote high-value care in a resource-limited setting based on real-world evidence

    by Ranin Soliman, Jason Oke, Iman Sidhom, Nickhill Bhakta, Nancy S. Bolous, Nourhan Tarek, Sonia Ahmed, Hany Abdelrahman, Emad Moussa, Manal Zamzam, et al.


  • 179 Evidence-based medicine teaching in medical schools in the eastern mediterranean region (EMR)

    by Ranin Soliman, Reham Khedr, Hanafy Hafez, Manal Zamzam, Alaa Elhaddad, Carl Heneghan

    Objectives To determine current status of evidence-based medicine (EBM) teaching in medical schools in the Eastern Mediterranean Region (EMR), and make recommendations for improvements in EBM educational infrastructure in medical schools in the region. Method We developed a modified version of a published survey instrument to assess EBM teaching on the undergraduate and post-graduate levels in medical schools in the EMR. The adapted surveys will be piloted with several medical schools, revised, then sent by email to school deans, department chairs, or full-time faculty members to complete the surveys and provide outline of their EBM curriculum. To increase the response rate, follow-up emails will be sent to non-responders two weeks after the first email. We shall offer a second round of survey administration and/or personally contact the remaining non-respondents. Survey sections include the availability of taught EBM course(s), content and topics covered, format of teaching, persons involved in teaching, problems and future plans. The study was approved by the institutional Scientific Medical Advisory Committee (SMAC). Results The online surveys will be sent to medical schools in countries in the EMR region including; Egypt, Algeria, Bahrain, Iraq, Jordan, Kuwait, Lebanon, Morocco, Oman, Saudi Arabia, Tunisia, United Arab Emirates. Minimum response rate accepted is 30-40% of total number of medical schools included. Study results will be available for presentation at the conference. Conclusions Determining the current situation of EBM teaching in medical schools in the MENA region will help make recommendations to address any challenges in EBM teaching and inform the strategies of medical schools in the region regarding EBM training and teaching.

  • Open Access

    Systematic review of costs and cost-effectiveness of treatment for relapsed/refractory acute leukemia in children and young adults

    by Ranin Soliman, Carl Heneghan, Nancy S. Bolous, Iman Sidhom, Sonia Ahmed, Nia Roberts, Jason Oke, Alaa Elhaddad

    Survival outcomes of children with relapsed/refractory (r/r) acute leukemia remain poor. Novel expensive treatments have been developed to improve their outcomes, yet, limited evidence exists about...


  • Childhood cancer hospital resource utilization and costs in Egypt, 2013‐2017; patterns, trends, and associated factors for 8886 patients from Children's Cancer Hospital, Egypt

    by Ranin Soliman, Alaa Elhaddad, Jason Oke, Wael Eweida, Nourhan Tarek, Mahmoud Hamza, Yaling Yang, Sherif Abouelnaga, Carl Heneghan

    Introduction: There is a lack ofevidence about resource use and costs of childhood cancer care in Egypt. Knowledge about resource use/costs can help in better resource planning to improve care and outcomes efficiently. In this study, we estimated patterns and trends of hospital resource use and costs for children with cancer (n = 8886, aged 0‐18 years) treated at Children's Cancer Hospital, Egypt (CCHE), between 2013 and 2017, by ICCC‐3 groups, at one and three years post‐diagnosis.Methods: We estimated costs from the healthcare provider perspective, expressed in USD 2019. We also studied resource use/cost trends, and factors associated with inpatient days and costs.Results: For all cancers combined, median costs were $14,774 (IQR: $6,559‐$23,738) at one year and $19,799 (IQR: $8,921‐$34,204) at three years post‐diagnosis. Median inpatient days were 38 days (IQR: 17‐60) at one year, and 43 days (IQR: 20‐74) at three years post‐diagnosis. Patients with acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and neuroblastoma imposed the greatest financial burden on CCHE, representing 53.1% of total costs. AML patients had the highest costs/resource use of all childhood cancers. Cost trends decreased by 2.9% (P < 0.001) for all cancers combined, due to economic instability in Egypt between 2013 and 2017. The use of IV supportive drugs increased by 24.3% (P < 0.001) over time for children with solid tumors.Conclusion: These findings will inform hospital resource planning and budgeting to promote value in care delivery, with implications for pediatric oncology practice and policy in Egypt/CCHE. Estimated costs provide the foundation for cost‐effectiveness analysis.


  • Open Access

    Temporal trends in childhood cancer survival in Egypt, 2007 to 2017: A large retrospective study of 14 808 children with cancer from the Children's Cancer Hospital Egypt

    by Ranin M. Soliman, Alaa Elhaddad, Jason Oke, Wael Eweida, Iman Sidhom, Sonia Ahmed, Hany Abdelrahman, Emad Moussa, Mohamed Fawzy, Manal Zamzam, et al.

    Childhood cancer is a priority in Egypt due to large numbers of children with cancer, suboptimal care and insufficient resources. It is difficult to evaluate progress in survival because of paucity of data in National Cancer Registry. In this study, we studied survival rates and trends in survival of the largest available cohort of children with cancer (n = 15 779, aged 0‐18 years) from Egypt between 2007 and 2017, treated at Children's Cancer Hospital Egypt‐(CCHE), representing 40% to 50% of all childhood cancers across Egypt. We estimated 5‐year overall survival (OS) for 14 808 eligible patients using Kaplan‐Meier method, and determined survival trends using Cox regression by single year of diagnosis and by diagnosis periods. We compared age‐standardized rates to international benchmarks in England and the United States, identified cancers with inferior survival and provided recommendations for improvement. Five‐year OS was 72.1% (95% CI 71.3‐72.9) for all cancers combined, and survival trends increased significantly by single year of diagnosis (P < .001) and by calendar periods from 69.6% to 74.2% (P < .0001) between 2007‐2012 and 2013‐2017. Survival trends improved significantly for leukemias, lymphomas, CNS tumors, neuroblastoma, hepatoblastoma and Ewing Sarcoma. Survival was significantly lower by 9% and 11.2% (P < .001) than England and the United States, respectively. Significantly inferior survival was observed for the majority of cancers. Although survival trends are improving for childhood cancers in Egypt/CCHE, survival is still inferior in high‐income countries. We provide evidence‐based recommendations to improve survival in Egypt by reflecting on current obstacles in care, with further implications on practice and policy.


  • Open Access

    19 Childhood cancer health outcomes in egypt: ten-year real-world evidence from children’s cancer hospital 57357 – egypt (CCHE) and comparison with results from england

    by Ranin Soliman, Alaa Elhaddad, Jason Oke, Wael Eweida, Iman Sidhom, Sonia Mahmoud, Hany Abdelrahman, Emad Moussa, Mohamed Sedki, Manal Zamzam, et al.

    Objectives To study childhood cancer survival and health outcomes over the last ten years in one Egyptian hospital CCHE (Children’s cancer Hospital 57357 Egypt); determine the variations in survival by demographic, cancer type, and disease severity differences and the reasons behind these variations; and compare childhood cancer survival outcomes with results from England. Method A retrospective observational cohort study was conducted for children (age 0-18 years) with confirmed cancer diagnosis who presented at CCHE for treatment from 2007 until 2017 and were followed up until July 2018. Confirmed diagnosis of childhood malignancy followed the WHO/ICCC-3 criteria. Patients’ demographic data were extracted from hospital-based cancer registry, while disease-related and health outcomes data were extracted from hospital disease-specific registry. Health outcomes included 5-year survival rates, age-standardized mortality rates, and trends in disease relapse/progression. Five-year overall survival was calculated for each childhood cancer type using Kaplan Meier analysis. The 5-year overall survival rates at CCHE were compared to population-based 5-year survival of children with cancer in England [2001–2015]. Comparable survival was defined as < 10% difference and > 10% as inferior survival. Patients’ demographics were described for the full-analysis population, and health outcomes evaluation was done for the evaluable population, based on intention-to-treat analysis. Results A total of 15,997 children with cancer were analyzed; 58% were males and 42% females. Most of the patients (48%) were in the youngest age group [0–4 years]. Fifty-nine percent of patients had solid tumors and 41% had hematologic malignancies. The most common cancers were Leukemia, Lymphoma, CNS tumors, and Neuroblastoma. Survival was calculated for 14,553 patients, representing 92.2% of full study population. 5-year survival rates at CCHE were comparable for some cancer types; 95.6% for Hodgkin’s Lymphoma; 81% for Non-Hodgkin’s Lymphoma; 92.3% for Retinoblastoma; 82% for Renal tumors; 66.4% for CNS tumors; 65.9% for Ewing Sarcoma; 86.9% for Germ cell tumors; 61% for Rhabdomyosarcoma; 77.1% for other soft tissue tumors; and 91.2% for CML. Whereas for other cancer types, overall survival rates at CCHE were inferior; 79.9% for ALL; 53.8% for AML; 56.5% for Neuroblastoma; 56.4% for Hepatoblastoma; 49.1% for Osteosarcoma. Trends in age-adjusted mortality-rates will presented. Conclusions Studying 5-year survival in childhood cancer health outcomes at CCHE would help generate real-world evidence about those having inferior outcomes and identify priority areas that need future improvements. Making better use of the evidence generated at CCHE would enhance real-world practice through making informed decisions that are adapted to a local context setting– CCHE.